Vascular Malformation
12
3
4
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
MiDura-Study (Neuro-Patch in Duraplasty)
Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation
suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study
Diagnostic Imaging of Vascular Malformations Using MSOT and ULM
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
A Study of Enalapril in Treatment of Venous Malformations
AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology
Bioseal Dural Sealing Study BIOS-14-001
Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding